Implantable LHRH agonist for treatment of prostate cancer.
Lajiness
Michelle J
MJ
Urology Associates, Beaumont Hospital, Royal Oak, MI, USA.
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D004343:Drug Implants; D006801:Humans; D016729:Leuprolide / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D018931:Antineoplastic Agents, Hormonal; D004343:Drug Implants; D016729:Leuprolide